Skip to main content

Merkel Cell Carcinoma

  • Chapter
  • First Online:
Neuroendocrine Tumors

Part of the book series: Current Clinical Oncology ((CCO))

Abstract

Merkel cell carcinoma is a rare and aggressive neuroendocrine malignancy. In this chapter, we summarize the current knowledge regarding its epidemiology, pathogenesis, clinical features, histopathologic features, clinical staging, and prognosis. Furthermore, we review the evidence for various therapeutic approaches, including surgery, radiation therapy, and chemotherapy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Toker C. Trabecular carcinoma of the skin. Arch Dermatol. 1972;105(1):107–10.

    Article  PubMed  CAS  Google Scholar 

  2. Tang CK, Toker C. Trabecular carcinoma of the skin: an ultrastructural study. Cancer. 1978;42(5):2311–21.

    Article  PubMed  CAS  Google Scholar 

  3. Pulitzer MP, Amin BD, Busam KJ. Merkel cell carcinoma: review. Adv Anat Pathol. 2009;16(3):135–44.

    Article  PubMed  Google Scholar 

  4. Swann MH, Yoon J. Merkel cell carcinoma. Semin Oncol. 2007;34(1):51–6.

    Article  PubMed  Google Scholar 

  5. Becker JC, Kauczok CS, Ugurel S, Eib S, Bröcker EB, Houben R. Merkel cell carcinoma: molecular pathogenesis, clinical features and therapy. J Dtsch Dermatol Ges. 2008;6(9):709–19.

    Article  PubMed  Google Scholar 

  6. Lemos B, Nghiem P. Merkel cell carcinoma: more deaths but still no pathway to blame. J Invest Dermatol. 2007;127(9):2100–3.

    Article  PubMed  CAS  Google Scholar 

  7. Hodgson NC. Merkel cell carcinoma: changing incidence trends. J Surg Oncol. 2005;89(1):1–4.

    Article  PubMed  Google Scholar 

  8. Heath M, Jaimes N, Lemos B, Mostaghimi A, Wang LC, Peñas PF, et al. Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features. J Am Acad Dermatol. 2008;58(3):375–81.

    Article  PubMed  Google Scholar 

  9. Miller RW, Rabkin CS. Merkel cell carcinoma and melanoma: etiological similarities and differences. Cancer Epidemiol Biomarkers Prev. 1999;8(2):153–8.

    PubMed  CAS  Google Scholar 

  10. Engels EA, Frisch M, Goedert JJ, Biggar RJ, Miller RW. Merkel cell carcinoma and HIV infection. Lancet. 2002;359(9305):497–8.

    Article  PubMed  Google Scholar 

  11. Friedlaender MM, Rubinger D, Rosenbaum E, Amir G, Siguencia E. Temporary regression of Merkel cell carcinoma metastases after cessation of cyclosporine. Transplantation. 2002;73(11):1849–50.

    Article  PubMed  Google Scholar 

  12. Izikson L, Nornhold E, Iyer JG, Nghiem P, Zeitouni NC. Merkel cell carcinoma associated with HIV: Review of 14 patients. AIDS. 2011;25(1):119–21.

    Google Scholar 

  13. Penn I, First MR. Merkel’s cell carcinoma in organ recipients: report of 41 cases. Transplantation. 1999;68(11):1717–21.

    Article  PubMed  CAS  Google Scholar 

  14. Feng H, Shuda M, Chang Y, Moore PS. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science. 2008;319(5866):1096–100.

    Article  PubMed  CAS  Google Scholar 

  15. Dubina M, Goldenberg G. Viral-associated nonmelanoma skin cancers: a review. Am J Dermatopathol. 2009;31(6):561–73.

    Article  PubMed  Google Scholar 

  16. Garneski KM, Warcola AH, Feng Q, Kiviat NB, Leonard JH, Nghiem P. Merkel cell polyomavirus is more frequently present in North American than Australian Merkel cell carcinoma tumors. J Invest Dermatol. 2009;129(1):246–8.

    Article  PubMed  CAS  Google Scholar 

  17. Becker JC, Houben R, Ugurel S, Trefzer U, Pföhler C, Schrama D. MC polyomavirus is frequently present in Merkel cell carcinoma of European patients. J Invest Dermatol. 2009;129(1):248–50.

    Article  PubMed  CAS  Google Scholar 

  18. Busam KJ, Jungbluth AA, Rekthman N, Coit D, Pulitzer M, Bini J, et al. Merkel cell polyomavirus expression in Merkel cell carcinomas and its absence in combined tumors and pulmonary neuroendocrine carcinomas. Am J Surg Pathol. 2009;33(9):1378–85.

    Article  PubMed  Google Scholar 

  19. Tolstov YL, Pastrana DV, Feng H, Becker JC, Jenkins FJ, Moschos S, et al. Human Merkel cell polyomavirus infection II. MCV is a common human infection that can be detected by conformational capsid epitope immunoassays. Int J Cancer. 2009;125(6):1250–6.

    Article  PubMed  CAS  Google Scholar 

  20. Shuda M, Feng H, Kwun HJ, Rosen ST, Gjoerup O, Moore PS, et al. T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus. Proc Natl Acad Sci U S A. 2008;105(42):16272–7.

    Article  PubMed  CAS  Google Scholar 

  21. Shuda M, Arora R, Kwun HJ, Feng H, Sarid R, Fernández-Figueras MT, et al. Human Merkel cell polyomavirus infection I. MCV T antigen expression in Merkel cell carcinoma, lymphoid tissues and lymphoid tumors. Int J Cancer. 2009;125(6):1243–9.

    Article  PubMed  CAS  Google Scholar 

  22. Agelli M, Clegg LX. Epidemiology of primary Merkel cell carcinoma in the United States. J Am Acad Dermatol. 2003;49(5):832–41.

    Article  PubMed  Google Scholar 

  23. Lunder EJ, Stern RS. Merkel-cell carcinomas in patients treated with methoxsalen and ultraviolet A radiation. NEJM. 1998;339(17):1247–8.

    Article  PubMed  CAS  Google Scholar 

  24. Popp S, Waltering S, Herbst C, Moll I, Boukamp P. UV-B-type mutations and chromosomal imbalances indicate common pathways for the development of Merkel and skin squamous cell carcinomas. Int J Cancer. 2002;99(3):352–60.

    Article  PubMed  CAS  Google Scholar 

  25. Paulson KG, Lemos BD, Feng B, Jaimes N, Peñas PF, Bi X, et al. Array-CGH reveals recurrent genomic changes in Merkel cell carcinoma including amplification of L-Myc. J Invest Dermatol. 2009;129(6):1547–55.

    Article  PubMed  CAS  Google Scholar 

  26. Walsh NM. Primary neuroendocrine (Merkel cell) carcinoma of the skin: morphologic diversity and implications thereof. Hum Pathol. 2001;32(7):680–9.

    Article  PubMed  CAS  Google Scholar 

  27. Medina-Franco H, Urist MM, Fiveash J, Heslin MJ, Bland KI, Beenken SW. Multimodality treatment of Merkel cell carcinoma: case series and literature review of 1024 cases. Ann Surg Oncol. 2001;8(3):204–8.

    Article  PubMed  CAS  Google Scholar 

  28. Smith KJ, Skelton III HG, Holland TT, Morgan AM, Lupton GP. Neuroendocrine (Merkel cell) carcinoma with an intraepidermal component. Am J Dermatopathol. 1993;15(6):528–33.

    Article  PubMed  CAS  Google Scholar 

  29. Lemos BD, Storer BE, Iyer JG, et al. Pathologic nodal evaluation improves prognostic ­accuracy in merkel cell carcinoma: Analysis of 5823 cases as the basis of the first consensus staging system. J Am Acad Dermatol. 2010;63(5):751–61.

    Google Scholar 

  30. Allen PJ, Bowne WB, Jaques DP, Brennan MF, Busam K, Coit DG. Merkel cell carcinoma: prognosis and treatment of patients from a single institution. J Clin Oncol. 2005;23(10):2300–9.

    Article  PubMed  Google Scholar 

  31. Bichakjian CK, Lowe L, Lao CD, Sandler HM, Bradford CR, Johnson TM, et al. Merkel cell carcinoma: critical review with guidelines for multidisciplinary management. Cancer. 2007;110(1):1–12.

    Article  PubMed  Google Scholar 

  32. Warner CL, Cockerell CJ. The new seventh edition American Joint Committee on cancer staging of cutaneous non-melanoma skin cancer: a critical review. Am J Clin Dermatol. 2011;12(3):147–154.

    Google Scholar 

  33. Andea AA, Coit DG, Amin B, Busam K. Merkel cell carcinoma: histologic features and prognosis. Cancer. 2008;113(9):2549–58.

    Article  PubMed  Google Scholar 

  34. Ruan JH, Reeves M. Merkel cell carcinoma treatment algorithm. Arch Surg. 2009;144(6):582–5.

    Article  PubMed  Google Scholar 

  35. Gillenwater AM, Hessel AC, Morrison WH, Burgess M, Silva EG, Roberts D, et al. Merkel cell carcinoma of the head and neck: effect of surgical excision and radiation on recurrence and survival. Arch Otolaryngol Head Neck Surg. 2001;127(2):149–54.

    PubMed  CAS  Google Scholar 

  36. O’Connor WJ, Roenigk RK, Brodland DG. Merkel cell carcinoma. Comparison of Mohs micrographic surgery and wide excision in eighty-six patients. Dermatol Surg. 1997;23(10):929–33.

    Article  PubMed  Google Scholar 

  37. Gollard R, Weber R, Kosty MP, Greenway HT, Massullo V, Humberson C. Merkel cell carcinoma: review of 22 cases with surgical, pathologic, and therapeutic considerations. Cancer. 2000;88(8):1842–51.

    Article  PubMed  CAS  Google Scholar 

  38. Zeitouni NC, Cheney RT, Delacure MD. Lymphoscintigraphy, sentinel lymph node biopsy, and Mohs micrographic surgery in the treatment of Merkel cell carcinoma. Dermatol Surg. 2000;26(1):12–8.

    Article  PubMed  CAS  Google Scholar 

  39. Snow SN, Larson PO, Hardy S, Bentz M, Madjar D, Landeck A, et al. Merkel cell carcinoma of the skin and mucosa: report of 12 cutaneous cases with 2 cases arising from the nasal mucosa. Dermatol Surg. 2001;27(2):165–70.

    Article  PubMed  CAS  Google Scholar 

  40. Boyer JD, Zitelli JA, Brodland DG, D’Angelo G. Local control of primary Merkel cell carcinoma: review of 45 cases treated with Mohs micrographic surgery with and without adjuvant radiation. J Am Acad Dermatol. 2002;47(6):885–92.

    Article  PubMed  Google Scholar 

  41. Pathai S, Barlow R, Williams G, Olver J. Mohs’ micrographic surgery for Merkel cell carcinomas of the eyelid. Orbit. 2005;24(4):273–5.

    Article  PubMed  Google Scholar 

  42. Mojica P, Smith D, Ellenhorn JD. Adjuvant radiation therapy is associated with improved survival in Merkel cell carcinoma of the skin. J Clin Oncol. 2007;25(9):1043–7.

    Article  PubMed  Google Scholar 

  43. Eng TY, Boersma MG, Fuller CD, Goytia V, Jones III WE, Joyner M, et al. A comprehensive review of the treatment of Merkel cell carcinoma. Am J Clin Oncol. 2007;30(6):624–36.

    Article  PubMed  Google Scholar 

  44. Grobmyer SR, Copeland III EM, Hochwald SN. Treatment of in-transit metastases from Merkel cell carcinoma with isolated hyperthermic limb infusion. Am Surg. 2008;74(12):1222–3.

    PubMed  Google Scholar 

  45. Zeitouni NC, Giordano CN, Kane JM 3rd. In-transit merkel cell carcinoma treated with isolated limb perfusion or isolated limb infusion: A case series of 12 patients. Dermatol Surg. 2011;37(3):357–64.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nathalie C. Zeitouni .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Izikson, L., Zeitouni, N.C. (2011). Merkel Cell Carcinoma. In: Yao, J., Hoff, P., Hoff, A. (eds) Neuroendocrine Tumors. Current Clinical Oncology. Humana Press. https://doi.org/10.1007/978-1-60327-997-0_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-60327-997-0_14

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-60327-996-3

  • Online ISBN: 978-1-60327-997-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics